以下是内容的中文翻译： 2026年初，对意大利控股公司Exor的投资被视为以显著折扣收购法拉利股票的机会。前提很简单：Exor作为法拉利最大的股东，其交易价格远低于其资产净值（NAV），这实际上让投资者能够以比法拉利独立股票估值更具吸引力的价格间接持有法拉利。 然而，自最初的推介以来，Exor已出售了价值30亿欧元的法拉利股份，其股价从86美元跌至79美元，其对NAV的折价已从最初的60%进一步扩大。这引发了人们对这项投资是否是错误的疑问。主持人认为答案处于一个“灰色地带”，因为尽管Exor的股票表现表面上令人失望，但其基础资产——法拉利，却持续创造着破纪录的业绩，并预计将迎来有史以来最好的一年。 尽管法拉利股票近期波动，但其业务依然异常强劲。它持续保持高利润率（EBITDA利润率约为40%），并拥有强大的定价权，自2017年以来，每单位平均收入从23.9万美元大幅增至44.6万美元。虽然管理层预计年收入增长率仅为5%，但公司的经营杠杆预计将扩大，研发投入占销售额的13%，经营利润率有望在2029年达到或超过30%。 一个关键事件是法拉利首款电动汽车Luce的发布。尽管最初遭遇了一些怀疑和短暂的股价下跌，但Luce销售良好，尤其是在中国等市场，其配额迅速售罄。法拉利CEO指出，Luce的订单已排到2027年末，这表明需求旺盛，并有望将法拉利的客户群扩展到科技前沿的买家。法拉利还推出了Testarossa Spider和Amulfi Spider等其他新车型，以满足不同价位的需求。 播客强调了法拉利独特的商业模式，利用稀缺性和品牌忠诚度。法拉利85%的销售额来自重复购买客户，并采用排队等候模式，这使其对经济衰退具有高度韧性。鉴于其超富裕的客户群以及通过产品组合和定制来抵消成本的能力，年轻人群驾照减少或关税等风险被认为对法拉利影响较小。F1赛车队继续作为有效的营销杠杆，巩固品牌传承。 关于Exor的行动，出售法拉利股票曾引起争议，但鉴于当时法拉利的高估值，这一举动被证明是及时的，为新的投资释放了资金。Exor的其他持股表现喜忧参半：汽车品牌集合体Stellantis股价大幅下跌，而CNH（约翰迪尔的竞争对手）和飞利浦表现较好。对依维柯（Iveco）和Gedi等公司的剥离，以及对LifeNet和Nuo的持股，都产生了资金，这表明Exor正在简化持股并可能更加专注。 Exor投资组合中值得注意的一部分是其资产管理部门Lingotto。自2023年成立以来，Lingotto的管理资产（AUM）已增至超过100亿美元，主要得益于强劲的投资回报，而不仅仅是资金流入。Teva制药和Carvana等持股取得了显著收益，这表明Lingotto在公开市场策略上取得了成功。尽管Lingotto为Exor贡献了收入，但更大的问题仍然是Exor能否持续有效地配置资本。 控股公司普遍存在的持续折价，以Prosus对其腾讯股份的巨大且持久的折价为例，仍然是一个问题。然而，主持人认为，与Exor历史上30%的平均水平相比，目前60%的折价异常之大。这项投资的论点在于法拉利内在价值的复合增长以及Exor对NAV的折价随着时间的推移而缩小，为回报提供了“双引擎”。 主持人指出了他们Exor投资论点的两个“终结标准”：Exor持续做出糟糕的资本配置决策（例如，避免回购而进行平庸的收购），或者CEO约翰·埃尔坎因持续的家族纠纷而失去对公司的控制。尽管短期股价表现不佳，但法拉利的基本面实力以及Exor巨大的交易折价，使主持人相信这项投资仍然是一个引人注目、不对称的赌注。

At the beginning of 2026, an investment in Exor, an Italian holding company, was presented as an opportunity to acquire Ferrari shares at a significant discount. The premise was simple: Exor, Ferrari's largest shareholder, traded at a massive discount to its net asset value (NAV), effectively allowing investors to own Ferrari indirectly at a much more attractive price than its standalone stock valuation. However, since the initial pitch, Exor has sold off 3 billion euros worth of its Ferrari stake, its stock is down from $86 to $79, and the discount to NAV has widened further from an initial 60%. This raises the question of whether the investment was a mistake. The hosts conclude that the answer lies in a "gray area" because while Exor's stock performance has been disappointing on paper, the underlying asset, Ferrari, continues to achieve record-breaking results and guides for its best year in history. Ferrari's business, despite its stock's recent volatility, remains incredibly strong. It consistently posts high margins (EBITDA margins around 40%) and has significant pricing power, with average revenue per unit rising drastically from $239,000 to $446,000 since 2017. While management projects a modest 5% annual revenue growth, the company's operating leverage is expected to expand, with R&D tracking at 13% of sales and operating margins potentially reaching or exceeding 30% by 2029. A key event was the launch of Ferrari's first electric vehicle, the Luce. While met with some initial skepticism and a brief stock dip, the Luce has sold well, particularly in markets like China where its allocation was quickly sold out. Ferrari's CEO noted a strong order book extending to late 2027 for the Luce, suggesting healthy demand and a potential expansion of Ferrari's customer base to tech-forward buyers. Ferrari also introduced other new models like the Testarossa Spider and Amulfi Spider, catering to different price points. The podcast emphasizes Ferrari's unique business model, leveraging scarcity and brand loyalty. With 85% of sales coming from repeat customers and a waiting list model, Ferrari is highly resilient to economic downturns. Risks like declining driving licenses among youth or tariffs are deemed less impactful for Ferrari, given its ultra-wealthy customer base and ability to offset costs through product mix and customization. The F1 racing team continues to serve as an effective marketing lever, reinforcing the brand's legacy. Regarding Exor's actions, the sale of Ferrari shares was controversial but proved timely given Ferrari's high valuation at the time, freeing up capital for new investments. Exor's other holdings present a mixed bag: Stellantis, a conglomeration of car brands, is down significantly, while CNH (a John Deere competitor) and Philips have performed better. Divestitures in companies like Iveco and Gedi, and stakes in LifeNet and Nuo, have generated capital, indicating a move towards simplifying holdings and potentially focusing more. A notable part of Exor's portfolio is Lingotto, its asset management division. Lingotto's assets under management (AUM) have tripled to over $10 billion since its 2023 inception, driven primarily by strong investment returns rather than just capital inflows. Holdings like Teva Pharmaceuticals and Carvana, which saw remarkable gains, illustrate Lingotto's successful public market strategies. While Lingotto contributes to Exor's income, the broader question remains whether Exor can consistently allocate capital effectively. The persistent discount of holding companies, exemplified by Prosus's large and enduring discount to its Tencent stake, remains a concern. However, the hosts argue that Exor's current 60% discount is unusually wide compared to its historical average of 30%. The investment thesis relies on Ferrari's intrinsic value compounding and Exor's discount to NAV narrowing over time, providing "two twin engines" for returns. The hosts identify two "kill criteria" for their Exor thesis: Exor making consistently poor capital allocation decisions (e.g., avoiding buybacks for mediocre acquisitions) or the CEO, John Elkann, losing control of the company due to ongoing family disputes. Despite the short-term stock performance, the fundamental strength of Ferrari and the significant discount at which Exor trades lead the hosts to believe the investment remains a compelling, asymmetric bet.